Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Selecting input/output components of a mobile terminal
Method and system for reduction of decoding complexity in a communication system
Anti-reductive high-frequency ceramic dielectric material sintered at low temperature and matched with copper internal electrode
Position and orientation measurement apparatus, position and orientation measurement method, and storage medium
Improving alignment target contrast in a lithographic double patterning process
Methods, systems, and media for swapping faces in images
Compatibility check
  Randomly Featured Patents
Method and apparatus for reducing soot particles in the exhaust gas of an internal combustion engine
Four stroke engine having flexible arrangement
Antibodies directed to the testis-specific tubulin tyrosine-ligase-like protein, BGS42
Method for the surface modification of formed bodies and formed bodies produced thereby
Scanner with interior gauging head and dust belt
Traveling wave, multiplying D/A converter
Truck conveyor
Compounds and methods for kinase modulation, and indications therefor
Resilient seating structure
Multi-channel tape head having asymmetric channel arrays